top of page

Mwandishi

Mhariri:

ULY CLINIC

Dkt. Benjamin L, MD

16 Machi 2021, 16:52:31

Dexamethasone na ujauzito

Dexamethasone na ujauzito

Dexamethasone ni dawa jamii ya corticosteroid yenye uwezo mkubwa wa kufanya kazi kama betamethasone.Matumizi ya dawa hii kipindi cha kwanza cha ujauzito huwa na madhara ya kusababisha mdomo sungura kwa data chache zilizopatikana kwa wamama wanaotumia dawa hii. Hata hivyo matumizi ya dawa hii yafanyike endapo faida kwa mama ni kubwa kuliko madhara yanayoweza kutokea kwa mtoto.


Ushauri dhidi ya matumizi kwa mama mjamzito


Inapatana na ujauzito endapo faida kwa mama >>kuliko hatari kwa Kijusi-kichanga tumboni


Inapatana na ujauzito endapo faida kwa mama >>ni kubwa kuliko hatari kwa Kijusi-kichanga tumboni, ina maana gani?

Kunaweza kuwa au kutokuwa na uzoefu wa matumizi ya dawa hii kwa binadamu, lakini faida ni kubwa zaidi zikitumiwa na mama kuliko madhara yanayofahamika au kutofahamika kuwa yanaweza kutokea kwa kijusi-kichanganya tumboni. Kwa mama dawa zinazidi madhara yanayofahammika. Taarifa za uzazi kwa wanyama hazina mahusiano.


Ushauri wa matumizi kwa mama anayenyonyesha


Hakuna (chache) taarifa za binadamu- Inawezekana patana na unyonyeshaji


Hakuna (chache) taarifa za binadamu- Inawezekana patana na unyonyeshaji, ina maana gani?

Hakuna taarifa za uzoefu kuhusu matumizi ya dawa hii kwa mama anayenyonyesha au kuna taarifa chache. Taarifa chache zilizopo zinaonyesha kuwa dawa hii haiwasilishi hatari yenye mashiko kwa kichanga anayenyonya maziwa ya mama anayetumia dawa.

ONYO: Usitumie dawa yoyote bila ushauri wa daktari. Dawa zinaweza kuleta madhara mwilini na pia matumizi ya baadhi ya dawa pasipo ushauri na vipimo husababisha  vimelea kuwa sugu dhidi ya dawa hiyo.
ULY clinic inakushauri kuwasiliana na daktari wako unapotaka kuchukua maamuzi yoyote yanayohusu afya yako.
Wasiliana na daktari/Mfamasia wa ULY clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kupiga simu au Kubonyeza Pata tiba chini ya tovuti hii.

Imeboreshwa,

4 Juni 2025, 19:18:36

​

  1. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet. 1999;86:242–4.

  2. Reck G, et al. Plasma levels of free estriol and cortisol under ACTH and dexamethasone during late pregnancy. Acta Endocrinol. 1977;84:86–7.

  3. Kauppilla A. ACTH levels in maternal, fetal and neonatal plasma after short term prenatal dexamethasone therapy. Br J Obstet Gynaecol. 1977;84:128–34.

  4. Warren JC, Cheatum SG. Maternal urinary estrogen excretion: effect of adrenal suppression. J Clin Endocrinol. 1967;27:436–8.

  5. Caspi I, et al. Changes in amniotic fluid lecithin-sphingomyelin ratio following maternal dexamethasone administration. Am J Obstet Gynecol. 1975;122:327–31.

  6. Spellacy WN, et al. Human amniotic fluid lecithin/sphingomyelin ratio changes with estrogen or glucocorticoid treatment. Am J Obstet Gynecol. 1973;115:216–8.

  7. Caspi E, Schreyer P, Weinraub Z, Reif R, Levi I, Mundel G. Prevention of the respiratory distress syndrome in premature infants by antepartum glucocorticoid therapy. Br J Obstet Gynaecol. 1976;83:187–93.

  8. Ballard RA, Ballard PL. Use of prenatal glucocorticoid therapy to prevent respiratory distress syndrome. Am J Dis Child. 1976;130:982–7.

  9. Thornfeldt RE, et al. The effect of glucocorticoids on the maturation of premature lung membranes: preventing the respiratory distress syndrome by glucocorticoids. Am J Obstet Gynecol. 1978;131:143–8.

  10. Ballard PL, Ballard RA. Corticosteroids and respiratory distress syndrome: status 1979. Pediatrics. 1979;63:163–5.

  11. Taeusch HW Jr, Frigoletto F, Kitzmiller J, Avery ME, Hehre A, Fromm B, Lawson E, Neff RK. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics. 1979;63:64–72.

  12. Caspi E, et al. Dexamethasone for prevention of respiratory distress syndrome: multiple perinatal factors. Obstet Gynecol. 1981;57:41–7.

  13. Bishop EH. Acceleration of fetal pulmonary maturity. Obstet Gynecol. 1981;58(Suppl):48S–51S.

  14. Farrell PM, et al. Amniotic fluid phospholipids after maternal administration of dexamethasone. Am J Obstet Gynecol. 1983;145:484–90.

  15. Ruvinsky ED, et al. Maternal administration of dexamethasone in severe pregnancy-induced hypertension. Am J Obstet Gynecol. 1984;149:722–6.

  16. Avery ME. The argument for prenatal administration of dexamethasone to prevent respiratory distress syndrome. J Pediatr. 1984;104:240.

  17. Sepkowitz S. Prenatal corticosteroid therapy to prevent respiratory distress syndrome. J Pediatr. 1984;105:338–9.

  18. Avery ME. Prenatal corticosteroid therapy to prevent respiratory distress syndrome (reply). J Pediatr. 1984;105:339.

  19. Levy DL. Maternal administration of dexamethasone to prevent RDS. J Pediatr. 1984;105:339.

  20. Eggers TR, Doyle LW, Pepperell RJ. Premature rupture of the membranes. Med J Aust. 1979;1:209–13.

  21. Garite TJ, et al. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. Am J Obstet Gynecol. 1981;141:508–15.

  22. Garite TJ. Premature rupture of the membranes: the enigma of the obstetrician. Am J Obstet Gynecol. 1985;151:1001–5.

  23. Curet LB, et al. Antenatal therapy with corticosteroids and postpartum complications. Am J Obstet Gynecol. 1985;152:83–4.

  24. Osathanondh R, et al. Dexamethasone levels in treated pregnant women and newborn infants. J Pediatr. 1977;90:617–20.

  25. Levitz M, Jansen V, Dancis J. The transfer and metabolism of corticosteroids in the perfused human placenta. Am J Obstet Gynecol. 1978;132:363–6.

  26. Otero L, et al. Neonatal leukocytosis associated with prenatal administration of dexamethasone. Pediatrics. 1981;68:778–80.

  27. Anday EK, Harris MC. Leukemoid reaction associated with antenatal dexamethasone administration. J Pediatr. 1982;101:614–6.

  28. Schatz M, et al. Corticosteroid therapy for the pregnant asthmatic patient. JAMA. 1975;233:804–7.

  29. Jenssen H, Wright PB. The effect of dexamethasone therapy in prolonged pregnancy. Acta Obstet Gynecol Scand. 1977;56:467–73.

  30. Navot D, et al. Effect of dexamethasone on amniotic fluid absorbance in Rh-sensitized pregnancy. Br J Obstet Gynaecol. 1982;89:456–8.

  31. Yin CS, Scott JR. Unsuccessful treatment of fetal immunologic thrombocytopenia with dexamethasone. Am J Obstet Gynecol. 1985;152:316–7.

  32. David M, Forest MG. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr. 1984;105:799–803.

  33. Evans MI, et al. Pharmacologic suppression of the fetal adrenal gland in utero. JAMA. 1985;253:1015–20.

  34. Taeusch HW Jr. Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity. J Pediatr. 1975;87:617–23.

  35. Johnson JWC, et al. Betamethasone and the rhesus fetus: multisystemic effects. Am J Obstet Gynecol. 1979;133:677–84.

  36. Wong YC, et al. Antenatal dexamethasone and subsequent lung growth. Arch Dis Child. 1982;57:536–8.

  37. Collaborative Group on Antenatal Steroid Therapy. Effects of antenatal dexamethasone administration in the infant: long-term follow-up. J Pediatr. 1984;104:259–67.

bottom of page